SciClone Pharmaceuticals (Holdings) Limited
HKEX:6600.HK
18.72 (HKD) • At close June 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q3 | 2019 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 1,809.191 | 1,809.191 | 1,612.032 | 1,612.032 | 1,671.829 | 1,671.829 | 1,312.72 | 2,127.488 | 1,823.053 | 1,118.986 | 1,151.967 | 919.49 |
| Short Term Investments
| 414.099 | 226.623 | 732.825 | 537.124 | 969.807 | 767.106 | 1,274.551 | 132.947 | 171 | 70.013 | 100.102 | 123.761 |
| Cash and Short Term Investments
| 2,223.29 | 2,223.29 | 2,344.857 | 2,344.857 | 2,641.636 | 2,641.636 | 2,587.271 | 2,260.435 | 1,994.053 | 1,188.999 | 1,252.069 | 1,043.251 |
| Net Receivables
| 867.954 | 867.954 | 1,007.634 | 962.571 | 816.806 | 780.962 | 833.114 | 562.287 | 768.578 | 547.553 | 655.025 | 387.66 |
| Inventory
| 308.285 | 308.285 | 115.519 | 115.519 | 140.56 | 140.56 | 149.876 | 174.66 | 146.128 | 171.585 | 123.837 | 140.199 |
| Other Current Assets
| 4.735 | 235.054 | 13.887 | 254.651 | 1.485 | 240.03 | 1.876 | 1.678 | 1.005 | 0.777 | 1.146 | 0.906 |
| Total Current Assets
| 3,447.107 | 3,447.107 | 3,481.897 | 3,481.897 | 3,600.487 | 3,600.487 | 3,572.137 | 2,999.06 | 2,909.764 | 1,908.914 | 2,032.077 | 1,572.016 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 39.421 | 39.421 | 21.641 | 21.641 | 28.625 | 28.625 | 34.303 | 29.878 | 26.615 | 14.264 | 16.375 | 35.103 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 396.039 | 396.039 | 491.262 | 491.262 | 542.241 | 542.241 | 548.7 | 606.095 | 610.232 | 652.691 | 567.911 | 169.251 |
| Goodwill and Intangible Assets
| 396.039 | 396.039 | 491.262 | 491.262 | 542.241 | 542.241 | 548.7 | 606.095 | 610.232 | 652.691 | 567.911 | 169.251 |
| Long Term Investments
| 110.637 | 110.637 | -554.526 | 178.299 | -826.706 | 143.101 | -1,107.918 | 360.785 | 118.357 | 218.275 | 91.087 | -61.299 |
| Tax Assets
| 0 | 0 | 0.651 | 0 | 0.651 | 0 | 3.055 | 1.52 | 11.388 | 13.336 | 0 | 0 |
| Other Non-Current Assets
| 7.046 | 7.046 | 738.187 | 6.013 | 975.108 | 5.952 | 1,279.815 | 65.344 | 176.04 | 75.164 | 105.105 | 130.752 |
| Total Non-Current Assets
| 553.143 | 553.143 | 697.215 | 697.215 | 719.919 | 719.919 | 757.955 | 1,063.622 | 942.632 | 973.73 | 780.478 | 273.807 |
| Total Assets
| 4,000.25 | 4,000.25 | 4,179.112 | 4,179.112 | 4,320.406 | 4,320.406 | 4,330.092 | 4,062.682 | 3,852.396 | 2,882.644 | 2,812.555 | 1,845.823 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 236.591 | 236.591 | 107.868 | 107.868 | 102.717 | 102.717 | 98.54 | 126.92 | 76.152 | 57.546 | 504.548 | 224.321 |
| Short Term Debt
| 13.064 | 0 | 445.351 | 433.548 | 430.59 | 417.876 | 416.776 | 393.933 | 398.115 | 789.39 | 417.355 | 19.466 |
| Tax Payables
| 62.08 | 0 | 89.603 | 0 | 42.09 | 0 | 24.375 | 25.035 | 91.422 | 84.283 | 81.699 | 62.812 |
| Deferred Revenue
| -13.064 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 91.422 | 84.283 | 0 | 0 |
| Other Current Liabilities
| 461.653 | 461.653 | 363.725 | 375.528 | 358.125 | 370.839 | 397.537 | 435.917 | 174.084 | 456.552 | 81.699 | 62.812 |
| Total Current Liabilities
| 698.244 | 698.244 | 916.944 | 916.944 | 891.432 | 891.432 | 912.853 | 956.77 | 739.773 | 1,387.771 | 1,003.602 | 306.599 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 19.768 | 19.768 | 433.382 | 433.382 | 422.037 | 422.037 | 815.135 | 773.335 | 1,172.37 | 1,173.559 | 1,634.452 | 6.992 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 16.963 | 0 | 14.564 | 0 | 14.57 | 0 | 17.312 | 14.981 | 11.054 | 9.258 | 8.289 | 6.24 |
| Other Non-Current Liabilities
| 0.208 | 17.171 | 0.212 | 14.776 | 0.205 | 14.775 | 0.197 | 0.188 | 0.191 | 0.194 | 0.202 | 0.815 |
| Total Non-Current Liabilities
| 36.939 | 36.939 | 448.158 | 448.158 | 436.812 | 436.812 | 832.644 | 788.504 | 1,183.615 | 1,183.011 | 1,642.943 | 14.047 |
| Total Liabilities
| 735.183 | 735.183 | 1,365.102 | 1,365.102 | 1,328.244 | 1,328.244 | 1,745.497 | 1,745.274 | 1,923.388 | 2,570.782 | 2,646.545 | 320.646 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0.216 | 0.216 | 0.213 | 0.213 | 0.237 | 0.237 | 0.232 | 0.232 | 0.229 | 0.192 | 0.192 | 0 |
| Retained Earnings
| 1,839.778 | 1,877.494 | 1,352.749 | 1,385.775 | 934.019 | 967.045 | 618.047 | 290.394 | 0 | 148.997 | 92.646 | 229.044 |
| Accumulated Other Comprehensive Income/Loss
| 410.564 | 372.848 | 415.739 | 415.739 | 314.458 | 314.458 | 223.569 | 0 | 0 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 1,014.509 | 1,014.509 | 1,045.309 | 1,012.283 | 1,743.448 | 1,710.422 | 1,742.747 | 2,026.782 | 1,928.779 | 162.673 | 73.172 | 1,296.133 |
| Total Shareholders Equity
| 3,265.067 | 3,265.067 | 2,814.01 | 2,814.01 | 2,992.162 | 2,992.162 | 2,584.595 | 2,317.408 | 1,929.008 | 311.862 | 166.01 | 1,525.177 |
| Total Equity
| 3,265.067 | 3,265.067 | 2,814.01 | 2,814.01 | 2,992.162 | 2,992.162 | 2,584.595 | 2,317.408 | 1,929.008 | 311.862 | 166.01 | 1,525.177 |
| Total Liabilities & Shareholders Equity
| 4,000.25 | 4,000.25 | 4,179.112 | 4,179.112 | 4,320.406 | 4,320.406 | 4,330.092 | 4,062.682 | 3,852.396 | 2,882.644 | 2,812.555 | 1,845.823 |